Inventor
MOUSA SHAKER
US16 patents
⚠️ This page may combine multiple inventors who share the name “MOUSA SHAKER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MOUSA SHAKER
5 patentsUS8507723B2Aug 13, 2013
Polycationic compounds and uses thereof
MOUSA SHAKER5 citations82
US8232428B2Jul 31, 2012
Polycationic compounds and uses thereof
MOUSA SHAKER10 citations82
US8129566B2Mar 6, 2012
Polycationic compounds and uses thereof
MOUSA SHAKER7 citations82
US7741311B2Jun 22, 2010
Composition and method for treating occlusive vascular diseases, nerve regeneration, and wound healing
MOUSA SHAKER13 citations82
US7736636B2Jun 15, 2010
Method for treating occlusive vascular diseases & wound healing
MOUSA SHAKER3 citations53
NANOPHARMACEUTICALS LLC
4 patentsUS9839614B2Dec 12, 2017
Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
NANOPHARMACEUTICALS LLC9 citations83
US10328043B1Jun 25, 2019
Composition and method for dual targeting in treatment of neuroendocrine tumors
NANOPHARMACEUTICALS LLC11 citations79
US11077082B2Aug 3, 2021
Composition and method for dual targeting in treatment of neuroendocrine tumors
NANOPHARMACEUTICALS LLC2 citations68
US11351137B2Jun 7, 2022
Composition and method for dual targeting in treatment of neuroendocrine tumors
NANOPHARMACEUTICALS LLC0 citations58
SEHGAL LAKSHMAN R
3 patentsUS8142992B2Mar 27, 2012
Platelet preservation package comprising a short to ultra-short acting antiplatelet agent and anticoagulant with an oxygen carrier
SEHGAL LAKSHMAN R8 citations83
US8129104B2Mar 6, 2012
Platelet preservation composition comprising a short to ultra-short acting antiplatelet agent and anticoagulant with hemoglobin
SEHGAL LAKSHMAN R6 citations83
US8129103B2Mar 6, 2012
Use of a platelet preservation composition comprising a short to ultra-short acting antiplatelet agent and anticoagulant with an oxygen carrier
SEHGAL LAKSHMAN R4 citations73